STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, reported on the status of its application to obtain approval to market the Company’s Visian ICL products in Japan. As anticipated, the Ministry of Health, Labour and Welfare’s Expert Meeting II was held at the end of July in Japan, at which time the STAAR Visian ICL products were considered for approval in the Japanese market.
Home » STAAR Surgical Reports Progress On Japanese Application For Approval Of Visian(TM) Implantable Collamer(R) Lens (ICL(TM))